Opportunity Information: Apply for SP 16 005
Apply for SP 16 005
- The HHS-SAMHS in the health sector is offering a public funding opportunity titled "Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths (PDO)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243.
- This funding opportunity was created on Mar 29, 2016 and posted on Mar 29, 2016.
- Applicants must submit their applications by May 31, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $11,000,000.00 in funding.
- The number of recipients for this funding is limited to 11 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths (PDO) opportunity (Funding Opportunity Number SP 16 005) is a discretionary federal health grant offered by the U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration (HHS-SAMHSA). It was posted on March 29, 2016, created the same day, and had an application deadline of May 31, 2016 (both the original and current closing dates reflect May 31, 2016). The program is structured as a cooperative agreement, meaning awardees can generally expect a more hands-on federal partnership than a typical grant, often involving substantial programmatic involvement from the funding agency in areas like implementation support, reporting, and performance monitoring.
The core purpose of the PDO program is to reduce prescription drug and opioid overdose-related deaths and adverse events among adults age 18 and older. The opportunity focuses on practical, near-term overdose mortality reduction by strengthening community response capacity. A major emphasis is placed on training first responders and other key community sectors to recognize and respond to overdoses and to prevent overdose-related deaths. In addition to training, the program supports secondary prevention strategies, specifically including the purchase and distribution of naloxone to first responders. Naloxone is an opioid overdose reversal medication, and distributing it to those most likely to arrive first at an overdose scene is intended to increase rapid reversal and improve survival outcomes.
Funding details indicate an award ceiling of $11,000,000, with an expected total of 11 awards. The funding activity category is health, and the listing is associated with CFDA number 93.243. Eligibility is listed broadly as "Others," with the note that applicants should consult the opportunity's eligibility clarification text for specifics, which typically means eligibility may include certain governmental entities, tribal organizations, or other community-based or public safety-related organizations depending on the full notice. Overall, the grant is aimed at equipping communities with training, protocols, and naloxone access so that overdoses are identified quickly, responded to effectively, and less likely to result in death or severe harm.
Frequently Asked Questions (FAQs): Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths (PDO)
What is the name of this grant opportunity?
The opportunity is titled Grants to Prevent Prescription Drug/Opioid Overdose-Related Deaths (PDO).
Who is the federal sponsor for this opportunity?
The grant is offered by the U.S. Department of Health and Human Services (HHS), specifically the Substance Abuse and Mental Health Services Administration (SAMHSA).
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is SP 16 005.
What type of federal funding is this?
This is a discretionary federal health grant.
What is the award mechanism (grant type)?
The program is structured as a cooperative agreement.
What does it mean that this is a cooperative agreement?
A cooperative agreement generally involves a more hands-on partnership with the federal agency than a typical grant. Based on the information provided, awardees can usually expect substantial programmatic involvement from the funder in areas such as implementation support, reporting, and performance monitoring.
What is the overall purpose of the PDO program?
The core purpose is to reduce prescription drug and opioid overdose-related deaths and adverse events among adults by strengthening community capacity to respond to overdoses and prevent overdose-related fatalities.
Who is the target population for this program?
The program focuses on adults age 18 and older.
What kinds of activities does the PDO program emphasize?
The opportunity emphasizes practical, near-term overdose mortality reduction by strengthening community response capacity, with a major focus on:
- Training first responders to recognize and respond to overdoses
- Training other key community sectors to recognize and respond to overdoses
- Implementing approaches intended to prevent overdose-related deaths
Does the program support naloxone purchase and distribution?
Yes. The program supports secondary prevention strategies that specifically include the purchase and distribution of naloxone to first responders.
Why does the opportunity focus on distributing naloxone to first responders?
Naloxone is an opioid overdose reversal medication. The intent of distributing it to first responders is to increase the likelihood of rapid overdose reversal by those most likely to arrive first at an overdose scene, improving survival outcomes.
What is the funding activity category for this opportunity?
The funding activity category is Health.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA 93.243.
When was this opportunity posted?
The opportunity was posted on March 29, 2016.
When was this opportunity created?
The opportunity was created on March 29, 2016.
What was the application deadline?
The application deadline was May 31, 2016. The information provided indicates both the original and current closing dates reflect May 31, 2016.
How much funding is available per award (award ceiling)?
The award ceiling listed is $11,000,000.
How many awards were expected?
The opportunity indicated an expected total of 11 awards.
Who is eligible to apply?
Eligibility is listed broadly as "Others". The opportunity notes that applicants should consult the eligibility clarification text for specifics, which typically means eligibility may include certain governmental entities, tribal organizations, or other community-based or public safety-related organizations, depending on the full notice.
What is the primary strategy for reducing overdose deaths under this program?
The primary strategy described is strengthening community overdose response capacity through training, improved response readiness, and access to naloxone for first responders so overdoses are identified quickly, responded to effectively, and less likely to result in death or severe harm.
Is this program focused on near-term results or longer-term system change?
Based on the information provided, the opportunity is oriented toward practical, near-term overdose mortality reduction by improving immediate community response.
Browse more opportunities from the same category: Health
Next opportunity: Partnerships for Countermeasures against Select Pathogens (R01)
Previous opportunity: Innovative Coordinated Access and Mobility Grants Program - 2016 NOFO
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for SP 16 005
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (SP 16 005) also looked into and applied for these:
| Funding Opportunity |
|---|
| Partnerships for Countermeasures against Select Pathogens (R01) Apply for RFA AI 16 034 Funding Number: RFA AI 16 034 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| HPV Roundtable: Creating a National Network of Partners to Promote Cancer Prevention through Human Papillomavirus Vaccination- Financed in Part by 2016 Prevention and Public Health Funds Apply for CDC RFA IP16 1602PPHF16 Funding Number: CDC RFA IP16 1602PPHF16 Agency: HHS-CDC-NCIRD Category: Health Funding Amount: $500,000 |
| New Technologies for the Glycosciences (R41/R42) Apply for PA 16 158 Funding Number: PA 16 158 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Cooperative Agreements for Tribal Behavioral Health Apply for SM 16 010 Funding Number: SM 16 010 Agency: HHS-SAMHS Category: Health Funding Amount: $200,000 |
| New Technologies for the Glycosciences (R43/R44) Apply for PA 16 157 Funding Number: PA 16 157 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Adult Maturational Changes and Dysfunctions in Emotion Regulation (R21) Apply for RFA MH 17 400 Funding Number: RFA MH 17 400 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Dental Faculty Development and Loan Repayment Program Apply for HRSA 16 182 Funding Number: HRSA 16 182 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Advancing National Public Health Institutes Globally Apply for CDC RFA GH14 141903CONT16 Funding Number: CDC RFA GH14 141903CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Support for Public Health Drinking Water Programs to Improve Efficiency & Effectiveness for Controlling Drinking Water Exposures Apply for CDC RFA EH15 150702CONT16 Funding Number: CDC RFA EH15 150702CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| Tribal Public Health Capacity Building and Quality Improvement Apply for CDC RFA OT13 130304CONT16 Funding Number: CDC RFA OT13 130304CONT16 Agency: HHS-CDC Category: Health Funding Amount: Case Dependent |
| NIH Director's Transformative Research Awards (R01) Apply for RFA RM 16 007 Funding Number: RFA RM 16 007 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| NIH Director's New Innovator Award Program (DP2) Apply for RFA RM 16 004 Funding Number: RFA RM 16 004 Agency: HHS-NIH11 Category: Health Funding Amount: $1,500,000 |
| NIH Pioneer Award Program (DP1) Apply for RFA RM 16 005 Funding Number: RFA RM 16 005 Agency: HHS-NIH11 Category: Health Funding Amount: $700,000 |
| Comprehensive Health Services Delivery (CHSD) Apply for RFA 621 16 000012 Funding Number: RFA 621 16 000012 Agency: USAID-TAN Category: Health Funding Amount: $325,211,110 |
| Capacity building for ecological surveillance of viral hemorrhagic fevers in Sierra Leone Apply for CDC RFA CK16 1605 Funding Number: CDC RFA CK16 1605 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| Program Supplements for Violence Intervention to Enhance Lives (Short Title: VITEL) Apply for TI 16 010 Funding Number: TI 16 010 Agency: HHS-SAMHS Category: Health Funding Amount: $70,000 |
| Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03) Apply for PA 16 163 Funding Number: PA 16 163 Agency: HHS-NIH11 Category: Health Funding Amount: $100,000 |
| Emerging Infections Programs Apply for CDC RFA CK17 1701 Funding Number: CDC RFA CK17 1701 Agency: HHS-CDC-NCEZID Category: Health Funding Amount: Case Dependent |
| CDC’s Collaboration with Academia to Strengthen Public Health Workforce Capacity Apply for CDC RFA OE12 120105CONT16 Funding Number: CDC RFA OE12 120105CONT16 Agency: HHS-CDC-CSELS Category: Health Funding Amount: Case Dependent |
| Establishment of Resource Centers for Dental, Oral and Craniofacial Tissue Regeneration Consortium (U24) Apply for RFA DE 17 001 Funding Number: RFA DE 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $2,500,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "SP 16 005", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.